Scientists have reported on a new method for searching for traces of neurons in the blood
- Новости
- Health
- Scientists have reported on a new method for searching for traces of neurons in the blood
Scientists from the United States have developed a method for isolating microscopic particles with the NRXN3 protein, which is closely related to neurons, from blood and cerebrospinal fluid. In the future, their contents may help to study the condition of nerve cells and look for signs of diseases. Why particles in the blood are of interest to neuroscientists and what prevents them from being used for diagnosis so far is in the Izvestia material.
Why look for traces of neurons in the blood
It is difficult to observe molecular changes in the brain: it is impossible to regularly obtain tissue samples for research. Therefore, scientists are looking for ways to extract information about nerve cells from available biological fluids. Extracellular vesicles, tiny particles surrounded by a membrane, are being studied for this purpose.
The cells secrete these particles. Inside there may be proteins and RNA of the cell from which the vesicle appeared. These molecules can provide clues about the condition of the cell. However, particles of different origins mix in the blood, and it is not easy to separate them according to this feature.
"This project started with the idea that the brain is very difficult to access, and it would be great to have ways to track what is happening in it at the molecular level over time," said Dmitry Ter-Hovhannisyan, the first author of the work.
What should be the protein to search for
The researchers formulated three selection conditions. The protein must pass through the vesicle membrane, be predominantly associated with neurons, and indeed be present on particles in the blood or cerebrospinal fluid. The latter is also called liquor.
The first condition is necessary for capture: the antibody binds to an externally accessible portion of the protein and helps to isolate the particle along with it. The second gives reason to assume its cellular origin. The third requires laboratory verification: information that neurons produce protein does not yet prove its presence on vesicles.
"The protein had to be transmembrane, so that when an antibody captures it, the vesicle is extracted along with it," Ter—Hovhannisyan explained.
The team compared data on gene activity in different tissues and individual cells to find the markers most closely associated with neurons. The results were then compared with a set of proteins on the vesicles.
Why cleaning the sample was important
Free proteins of biological fluids interfered with this stage. It is especially difficult to work with blood plasma, where there is a lot of albumin. Even a small amount of it remaining in the preparation can make it difficult to detect much less common molecules associated with vesicles.
To reduce contamination, the authors have developed a way to purify MMR slurry. Porous granules are added to the sample: small free proteins, including albumin, enter the pores, while larger vesicles do not penetrate there. This way, researchers get material that is easier to analyze.
After purification, the team used mass spectrometry to determine the protein composition of the particles. This made it possible to compare the candidate features calculated on a computer with experimental data. The method also has independent applications: cleaner samples can help to study changes in the protein composition of vesicles in various diseases. That is why the authors consider cleaning as one of the essential results of their work.
What did the NRXN3 checks show?
Based on the results of the selection, the researchers created highly sensitive Simoa tests to test three candidate proteins. One of them, NRXN3, was confirmed on extracellular vesicles in both blood plasma and cerebrospinal fluid.
The team used different ways to isolate and detect particles, as well as visualize them. In one of these analyses, NRXN3-positive particles were found in all 36 examined plasma and cerebrospinal fluid samples. In addition, the scientists improved the capture using antibodies and were able to isolate vesicles with this protein.
If the antibody binds to a free-floating protein, the resulting material may not reflect the contents of the desired particles. Therefore, the authors checked what exactly is extracted from the sample. Ter-Hovhannisyan noted that there had been unsuccessful attempts in this area before: scientists used antibodies to the alleged markers, although the presence of the corresponding proteins on the vesicles had not been reliably established.
Why the origin of particles still needs to be proved
The main limitation remains: the researchers have not yet confirmed that the isolated vesicles actually appeared in the neurons. The association of NRXN3 with nerve cells makes it a promising candidate, but additional data is needed to determine the origin of the particles.
The next step is to check whether the contents of the captured vesicles are enriched with proteins or RNA characteristic of neurons. Such a check will help to understand how accurately the selected surface marker indicates the source of the particle.
"It needs to be confirmed that the vesicles isolated using a certain putative neuron-specific marker actually originate from neurons," Ter-Hovhannisyan emphasized.
The task is complicated by the small amount of RNA and proteins inside the vesicles. Particularly sensitive methods are needed to detect them. Another problem is the availability of antibodies: For many of the markers the team is interested in, there are no high-quality commercial reagents, so the laboratory develops its own.
How the method can help study diseases
The team's long—term goal is to find out whether vesicles of neural origin found in blood are capable of carrying signs of neurodegenerative diseases before symptoms appear. So far, the work is creating tools for such a search.
For diagnostic use, it is necessary to determine both the source of the particles and what changes in their contents are associated with a particular disease. The detection of NRXN3 on vesicles alone does not solve these issues.
The approach may also be useful outside of neuroscience. Ter-Hovhannisyan gave an example of the possible isolation of vesicles of liver or heart muscle cells to study diseases of the relevant organs. To do this, you will need to select and check the appropriate markers.
Переведено сервисом «Яндекс Переводчик»